Take a look at the companies that make headlines on Tuesday after the clock:
Atlassian – Shares of the Australian software company rose 1% as a result of the revised fiscal third quarter revenue guidance. Atlassian now expects revenue between $ 566 million and $ 572 million. Analysts surveyed by FactSet previously forecast revenue of $ 487.2 million for the third quarter. The new forecast is also above Atlassian’s previous forecast for the quarter.
Stitch Fix – The share of the personal styling service decreased by 3.2% after the company announced that Katrina Lake, founder and CEO, will become the CEO and Elizabeth Spaulding will take over as CEO from 1 August.
Endo International – The pharmaceutical company’s shares rose slightly after the company announced promising Phase 3 data on a cellulite treatment in the official journal of the American Society of Dermatologic Surgery. The data showed that the treatment offers a clinically significant improvement in the incidence of moderate to severe cellulite in the buttocks of adult women compared to placebo.
Amicus Therapeutics – The biopharmaceutical company’s share rose 3% after Cantor Fitzgerald’s analysts upgraded the stock to overweight, citing the company’s promising gene therapy results.
Discovery – Discovery’s A and C shares fell 3.8% and 5.1% respectively, after David Faber of CNBC reported that Credit Suisse will continue to downgrade positions in the media company due to the inflation of Archegos Capital Management . Referring to traders, Credit Suisse sold 19 million of the A shares of the media company and 22 million of the C shares.